<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34782065</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1550-9397</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>18</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine</Title>
          <ISOAbbreviation>J Clin Sleep Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Circulating C-reactive protein levels in patients with suspected obstructive sleep apnea.</ArticleTitle>
        <Pagination>
          <StartPage>993</StartPage>
          <EndPage>1001</EndPage>
          <MedlinePgn>993-1001</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.5664/jcsm.9774</ELocationID>
        <Abstract>
          <AbstractText Label="STUDY OBJECTIVES" NlmCategory="OBJECTIVE">To assess determinants of C-reactive protein (CRP) in a cohort of patients referred for investigation of obstructive sleep apnea (OSA) and to determine whether the overlap of OSA and chronic obstructive pulmonary disease (overlap syndrome) is associated with higher levels of CRP.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This was a cross-sectional study that included 2,352 patients seen at the West Australian Sleep Disorders Research Institute between 2006 and 2010. All patients had circulating CRP levels measured and spirometry performed. OSA was defined as an apnea-hypopnea index ≥ 5 events/h, and chronic obstructive pulmonary disease was defined as a forced expiratory volume in 1 second/forced vital capacity ratio &lt; 0.70 and age &gt; 40 years. Univariate and multivariate regression analysis were used to identify CRP determinants.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean age was 51 years (60% male), the median apnea-hypopnea index was 27 events/h, the median 3% oxygen desaturation index was 24 events/h, the mean forced expiratory volume in 1 second was 88% predicted, and the median CRP was 3.0 mg/L. In multivariate analyses, age, body mass index, female sex, neck circumference, apnea-hypopnea index, and desaturation markers (nadir and mean oxygen saturation) were independently associated with higher CRP. Spirometric variables were not predictors. There was no significant difference in CRP among patients with OSA with or without coexisting chronic obstructive pulmonary disease.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Markers of OSA severity (apnea-hypopnea index and oxygenation), age, body mass index, neck circumference, and female sex were independent predictors of circulating CRP levels. OSA overlapping with chronic obstructive pulmonary disease was not associated with increased CRP compared to either condition alone, suggesting other mechanisms for the increased cardiovascular disease risk in overlap syndrome. Recognizing factors that predict CRP will help identify patients at higher risk of cardiovascular disease and aid risk stratification.</AbstractText>
          <AbstractText Label="CITATION" NlmCategory="BACKGROUND">Shah A, Mukherjee S, McArdle N, Singh B, Ayas N. Circulating C-reactive protein levels in patients with suspected obstructive sleep apnea. <i>J Clin Sleep Med.</i> 2022;18(4):993-1001.</AbstractText>
          <CopyrightInformation>© 2022 American Academy of Sleep Medicine.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shah</LastName>
            <ForeName>Aditi</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Leon Judah Blackmore Sleep Disorders Program, University of British Columbia Hospital, Vancouver, British Columbia, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mukherjee</LastName>
            <ForeName>Sutapa</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Adelaide Institute for Sleep Health: A Flinders Centre for Research Excellence, College of Medicine and Public Health, Bedford Park, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sleep Health Service, Respiratory and Sleep Service, Southern Adelaide Local Health Network, Bedford Park, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McArdle</LastName>
            <ForeName>Nigel</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>West Australian Sleep Disorders Research Institute, Department of Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Human Sciences, University of Western Australia, Crawley, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Singh</LastName>
            <ForeName>Bhajan</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>West Australian Sleep Disorders Research Institute, Department of Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Human Sciences, University of Western Australia, Crawley, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ayas</LastName>
            <ForeName>Najib</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Leon Judah Blackmore Sleep Disorders Program, University of British Columbia Hospital, Vancouver, British Columbia, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Critical Care Division, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Clin Sleep Med</MedlineTA>
        <NlmUniqueID>101231977</NlmUniqueID>
        <ISSNLinking>1550-9389</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>9007-41-4</RegistryNumber>
          <NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D029424" MajorTopicYN="Y">Pulmonary Disease, Chronic Obstructive</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020181" MajorTopicYN="Y">Sleep Apnea, Obstructive</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">CRP</Keyword>
        <Keyword MajorTopicYN="N">obstructive sleep apnea</Keyword>
        <Keyword MajorTopicYN="N">polysomnography</Keyword>
        <Keyword MajorTopicYN="N">spirometry</Keyword>
        <Keyword MajorTopicYN="N">systemic inflammation</Keyword>
      </KeywordList>
      <CoiStatement>All authors have seen and approved the manuscript. Work for this study was performed at the West Australian Sleep Disorders Research Institute at Sir Charles Gairdner Hospital in Perth, Western Australia. Funding for the Western Australian Sleep Health Study was provided by the Sir Charles Gairdner and Hollywood Private Hospital Research Foundations, the State Health Research Advisory Council of Western Australia, the West Australian Sleep Disorders Research Institute, and the Centre for Genetic Epidemiology and Biostatistics, University of Western Australia. The authors report no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>4</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>16</Day>
          <Hour>5</Hour>
          <Minute>46</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34782065</ArticleId>
        <ArticleId IdType="pmc">PMC8974364</ArticleId>
        <ArticleId IdType="doi">10.5664/jcsm.9774</ArticleId>
        <ArticleId IdType="pii">jcsm.9774</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>

Danesh
 
J
, 
Whincup
 
P
, 
Walker
 
M
, et al. 
. 
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
. 

BMJ.

 
2000. 
;
321


(7255
):
199
–
204
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC27435</ArticleId>
            <ArticleId IdType="pubmed">10903648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Kaptoge
 
S
, 
Di Angelantonio
 
E
, 
Lowe
 
G
, et al. 
; 
Emerging Risk Factors Collaboration
. 
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
. 

Lancet.

 
2010. 
;
375


(9709
):
132
–
140
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3162187</ArticleId>
            <ArticleId IdType="pubmed">20031199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Torres
 
JL
, 
Ridker
 
PM

. 
Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events
. 

Curr Opin Cardiol.

 
2003. 
;
18
(
6
):
471
–
478
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14597888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Meier-Ewert
 
HK
, 
Ridker
 
PM
, 
Rifai
 
N
, 
Price
 
N
, 
Dinges
 
DF
, 
Mullington
 
JM

. 
Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects
. 

Clin Chem.

 
2001. 
;
47
(
3
):
426
–
430
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11238292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ayas
 
NT
, 
Hirsch Allen
 
AJ
, 
Fox
 
N
, et al. 
. 
C-reactive protein levels and the risk of incident cardiovascular and cerebrovascular events in patients with obstructive sleep apnea
. 

Lung.

 
2019. 
;
197
(
4
):
459
–
464
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31089857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Benjafield
 
AV
, 
Ayas
 
NT
, 
Eastwood
 
PR
, et al. 
. 
Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis
. 

Lancet Respir Med.

 
2019. 
;
7
(
8
):
687
–
698
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7007763</ArticleId>
            <ArticleId IdType="pubmed">31300334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Peres
 
BU
, 
Allen
 
AJH
, 
Kendzerska
 
T
, et al. 
. 
Obstructive sleep apnea severity, body mass index, and circulating levels of cellular adhesion molecules
. 

Lung.

 
2020. 
;
198


(6
):
939
–
945
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33141304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Peres
 
BU
, 
Allen
 
AJH
, 
Shah
 
A
, et al. 
. 
Obstructive sleep apnea and circulating biomarkers of oxidative stress: a cross-sectional study
. 

Antioxidants (Basel).

 
2020. 
;
9
(
6
):
476


.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7346202</ArticleId>
            <ArticleId IdType="pubmed">32498324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ayas
 
NT
, 
Taylor
 
CM
, 
Laher
 
I

. 
Cardiovascular consequences of obstructive sleep apnea
. 

Curr Opin Cardiol.

 
2016. 
;
31
(
6
):
599
–
605
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27652812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Shamsuzzaman
 
AS
, 
Winnicki
 
M
, 
Lanfranchi
 
P
, et al. 
. 
Elevated C-reactive protein in patients with obstructive sleep apnea
. 

Circulation.

 
2002. 
;
105
(
21
):
2462
–
2464
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12034649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Kendzerska
 
T
, 
Leung
 
RS
, 
Aaron
 
SD
, 
Ayas
 
N
, 
Sandoz
 
JS
, 
Gershon
 
AS

. 
Cardiovascular outcomes and all-cause mortality in patients with obstructive sleep apnea and chronic obstructive pulmonary disease (overlap syndrome)
. 

Ann Am Thorac Soc.

 
2019. 
;
16
(
1
):
71
–
81
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30372124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

McNicholas
 
WT

. 
COPD-OSA overlap syndrome: evolving evidence regarding epidemiology, clinical consequences, and management
. 

Chest.

 
2017. 
;
152
(
6
):
1318
–
1326
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28442310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Huang
 
T
, 
Goodman
 
M
, 
Li
 
X
, et al. 
. 
C-reactive protein and risk of OSA in four US cohorts
. 

Chest.

 
2021. 
;
159
(
6
):
2439
–
2448
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8213962</ArticleId>
            <ArticleId IdType="pubmed">33529772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Rasmussen
 
F
, 
Mikkelsen
 
D
, 
Hancox
 
RJ
, et al. 
. 
High-sensitive C-reactive protein is associated with reduced lung function in young adults
. 

Eur Respir J.

 
2009. 
;
33
(
2
):
382
–
388
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19010993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Jiang
 
R
, 
Burke
 
GL
, 
Enright
 
PL
, et al. 
. 
Inflammatory markers and longitudinal lung function decline in the elderly
. 

Am J Epidemiol.

 
2008. 
;
168
(
6
):
602
–
610
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2727196</ArticleId>
            <ArticleId IdType="pubmed">18687665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Mukherjee
 
S
, 
Hillman
 
D
, 
Lee
 
J
, et al. 
. 
Cohort profile: the Western Australian Sleep Health Study
. 

Sleep Breath.

 
2012. 
;
16
(
1
):
205
–
215
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21318257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Berry
 
RB
, 
Brooks
 
R
, 
Gamaldo
 
C
, et al. 
. 
AASM Scoring Manual updates for 2017 (version 2.4)
. 

J Clin Sleep Med.

 
2017. 
;
13
(
5
):
665
–
666
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5406946</ArticleId>
            <ArticleId IdType="pubmed">28416048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Miller
 
MR
, 
Hankinson
 
J
, 
Brusasco
 
V
, et al. 
 
ATS/ERS Task Force
. 
Standardisation of spirometry
. 

Eur Respir J.

 
2005. 
;
26
(
2
):
319
–
338
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16055882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ito
 
E
, 
Inoue
 
Y

. 
The International Classification of Sleep Disorders, third edition. American Academy of Sleep Medicine. Includes bibliographies and index. Article in Japanese
. 

Nihon Rinsho.

 
2015. 
;
73
(
6
):
916
–
923
.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26065120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Rabe
 
KF
, 
Hurd
 
S
, 
Anzueto
 
A
, et al. 
; 
Global Initiative for Chronic Obstructive Lung Disease
. 
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
. 

Am J Respir Crit Care Med.

 
2007. 
;
176
(
6
):
532
–
555
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17507545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Nadeem
 
R
, 
Molnar
 
J
, 
Madbouly
 
EM
, et al. 
. 
Serum inflammatory markers in obstructive sleep apnea: a meta-analysis
. 

J Clin Sleep Med.

 
2013. 
;
9
(
10
):
1003
–
1012
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3778171</ArticleId>
            <ArticleId IdType="pubmed">24127144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Kheirandish-Gozal
 
L
, 
Gozal
 
D

. 
Obstructive sleep apnea and inflammation: proof of concept based on two illustrative cytokines
. 

Int J Mol Sci.

 
2019. 
;
20
(
3
):
E459
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6387387</ArticleId>
            <ArticleId IdType="pubmed">30678164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Zhang
 
C
, 
Cheng
 
Y
, 
Liu
 
F
, 
Ma
 
J
, 
Wang
 
G

. 
A community study of the risk for obstructive sleep apnea and respiratory inflammation in an adult Chinese population
. 

Postgrad Med.

 
2021. 
;
133
(
5
):
531
–
540
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33851902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Guijarro
 
C

. 
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease
. 

Circulation.

 
2001. 
;
104
(
22
):
E127
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11723039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Vgontzas
 
AN
, 
Papanicolaou
 
DA
, 
Bixler
 
EO
, et al. 
. 
Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia
. 

J Clin Endocrinol Metab.

 
2000. 
;
85
(
3
):
1151
–
1158
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10720054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Kritikou
 
I
, 
Basta
 
M
, 
Vgontzas
 
AN
, et al. 
. 
Sleep apnea, sleepiness, inflammation and insulin resistance in middle-aged men and women
. 

Eur Respir J.

 
2014. 
;
43
(
1
):
145
–
155
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23598957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Gaines
 
J
, 
Kong
 
L
, 
Li
 
M
, et al. 
. 
C-reactive protein improves the ability to detect cardiometabolic risk in mild-to-moderate obstructive sleep apnea
. 

Physiol Rep.

 
2017. 
;
5
(
18
):
e13454
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5617934</ArticleId>
            <ArticleId IdType="pubmed">28947597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Guilleminault
 
C
, 
Kirisoglu
 
C
, 
Ohayon
 
MM

. 
C-reactive protein and sleep-disordered breathing
. 

Sleep.

 
2004. 
;
27
(
8
):
1507
–
1517
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15683141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Vgontzas
 
AN
, 
Papanicolaou
 
DA
, 
Bixler
 
EO
, 
Kales
 
A
, 
Tyson
 
K
, 
Chrousos
 
GP

. 
Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity
. 

J Clin Endocrinol Metab.

 
1997. 
;
82
(
5
):
1313
–
1316
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9141509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Muraki
 
I
, 
Tanigawa
 
T
, 
Yamagishi
 
K
, et al. 
; 
CIRCS Investigators
. 
Nocturnal intermittent hypoxia and C reactive protein among middle-aged community residents: a cross-sectional survey
. 

Thorax.

 
2010. 
;
65
(
6
):
523
–
527
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20522850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Dewan
 
NA
, 
Nieto
 
FJ
, 
Somers
 
VK

. 
Intermittent hypoxemia and OSA: implications for comorbidities
. 

Chest.

 
2015. 
;
147
(
1
):
266
–
274
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4285080</ArticleId>
            <ArticleId IdType="pubmed">25560865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Sharma
 
SK
, 
Mishra
 
HK
, 
Sharma
 
H
, et al. 
. 
Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi
. 

Sleep Med.

 
2008. 
;
9
(
2
):
149
–
156
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17638590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Wei
 
J
, 
Xiong
 
XF
, 
Lin
 
YH
, 
Zheng
 
BX
, 
Cheng
 
DY

. 
Association between serum interleukin-6 concentrations and chronic obstructive pulmonary disease: a systematic review and meta-analysis
. 

PeerJ.

 
2015. 
;
3
:
e1199
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4556145</ArticleId>
            <ArticleId IdType="pubmed">26336642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Yao
 
Y
, 
Zhou
 
J
, 
Diao
 
X
, 
Wang
 
S

. 
Association between tumor necrosis factor-α and chronic obstructive pulmonary disease: a systematic review and meta-analysis
. 

Ther Adv Respir Dis.

 
2019. 
;
13
:
1753466619866096
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6688146</ArticleId>
            <ArticleId IdType="pubmed">31390957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Minoguchi
 
K
, 
Tazaki
 
T
, 
Yokoe
 
T
, et al. 
. 
Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome
. 

Chest.

 
2004. 
;
126
(
5
):
1473
–
1479
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15539715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ciftci
 
TU
, 
Kokturk
 
O
, 
Bukan
 
N
, 
Bilgihan
 
A

. 
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome
. 

Cytokine.

 
2004. 
;
28
(
2
):
87
–
91
. 
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15381186</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
